ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CERE Cerevel Therapeutics Holdings Inc

42.155
0.555 (1.33%)
Last Updated: 15:59:15
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Cerevel Therapeutics Holdings Inc CERE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.555 1.33% 42.155 15:59:15
Open Price Low Price High Price Close Price Prev Close
41.88 41.70 42.21 41.60
more quote information »

Recent News

Date Time Source Heading
4/18/202406:30GLOBECerevel Therapeutics Announces Positive Topline Results for..
2/27/202416:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/16/202416:46EDGAR2Form 8-K - Current report
2/09/202409:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2/08/202419:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202408:30PRNUSKuehn Law Encourages MDC, WAVD, NS and CERE Investors to..
1/23/202417:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202417:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202417:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202417:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202417:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202417:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202407:44EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
1/18/202407:19EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
1/05/202417:13EDGAR2Form PREM14A - Preliminary proxy statements relating to..
1/02/202418:10PRNUSKuehn Law Encourages CERE, HA, IMGN, and WAVD Investors to..
12/28/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/28/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/26/202317:03EDGAR2Form 144 - Report of proposed sale of securities
12/21/202320:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/21/202320:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/21/202320:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/21/202320:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/21/202320:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/19/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202318:34EDGAR2Form 144 - Report of proposed sale of securities
12/11/202316:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/08/202317:00EDGAR2Form SC 13D/A - General statement of acquisition of..
12/08/202306:23IHMARKETNEWSApple Boosts Vietnam Production, Broadcom Revenue Miss,..
12/07/202319:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/07/202316:32EDGAR2Form 144 - Report of proposed sale of securities
12/07/202316:31EDGAR2Form 144 - Report of proposed sale of securities
12/07/202308:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/07/202308:00EDGAR2Form 8-K - Current report
12/07/202306:23IHMARKETNEWSAlphabet Unveils Advanced AI Model, AMD Expects $45 Billion..
12/06/202323:24PRNUSCERE MERGER ANNOUNCEMENT: Julie & Holleman LLP Announces..
12/06/202316:30PRNUSAbbVie to Acquire Cerevel Therapeutics in Transformative..
12/05/202318:42EDGAR2Form 144 - Report of proposed sale of securities
11/29/202306:30GLOBECerevel Therapeutics to Host Investor Webcast on Tavapadon..
11/08/202306:30GLOBECerevel Therapeutics to Present at Upcoming Investor..
11/01/202306:39EDGAR2Form 8-K - Current report
11/01/202306:30GLOBECerevel Therapeutics Reports Third Quarter 2023 Financial..
10/18/202316:32EDGAR2Form SC 13D/A - General statement of acquisition of..
10/13/202306:30GLOBECerevel Therapeutics to Report Third Quarter 2023 Financial..
10/12/202316:19EDGAR2Form 8-K - Current report
10/12/202316:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/11/202322:45GLOBECerevel Therapeutics Announces Pricing of $450 Million..
10/11/202316:14EDGAR2Form 8-K - Current report
10/11/202316:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/11/202316:01GLOBECerevel Therapeutics Announces Proposed Public Offering of..

Your Recent History

Delayed Upgrade Clock